 |
 |
|
|
RESÚMENES OCTUBRE 2006 |
Mood - Anxiety
Disorders & Antidepressants – Mood Stabilizers
(Haga un click en la información del journal para acceder al resúmen)
Adjunctive quetiapine for serotonin reuptake inhibitor-resistant obsessive-compulsive disorder: a meta-analysis of randomized controlled
treatment trials
Fineberg, Naomi A; Stein, Dan J; Premkumar, Preethi; Carey, Paul; Sivakumaran, Thanusha; Vythilingum, Bavanisha; Seedat, Soraya; Westenberg, Herman; Denys, Damiaan
International Clinical Psychopharmacology. 21(6):337-343, November
2006
Efficacy of duloxetine in painful symptoms: an analgesic or
antidepressant effect?
Perahia, David G.S; Pritchett, Yili L; Desaiah,
Durisala; Raskin, Joel
International
Clinical Psychopharmacology. 21(6):311-317, November 2006
Review of the epidemiological literature on
antidepressant use and breast cancer risk
Patricia F Coogan
Expert Review of Neurotherapeutics. September 2006, Vol. 6, No. 9, Pages 1363-1374
Bupropion: pharmacology and therapeutic applications
Kevin F Foley, Kevin P DeSanty and Richard E Kast
Expert Review of Neurotherapeutics. September 2006, Vol. 6, No. 9, Pages 1249-1265
Onset of
Spontaneous Panic Attacks: A Prospective Study of Risk Factors
William Coryell, Lilian Dindo,
Abby Fyer, and Daniel S. Pine
Psychosomatic Medicine
68:754-757 (2006)
Medical Comorbidity in Women and Men With
Bipolar Disorders: A Population-Based Controlled Study
Caroline P. Carney, and Laura E. Jones
Psychosomatic Medicine
68:684-691 (2006)
Course of
Depressive Symptoms After Myocardial Infarction and
Cardiac Prognosis: A Latent Class Analysis
Kirsten I. Kaptein, Peter de Jonge, Rob H. S. van den Brink, and Jakob
Korf
Psychosomatic Medicine
68:662-668 (2006)
Phobic Anxiety,
Depression, and Risk of Ventricular Arrhythmias in Patients With
Coronary Heart Disease
Lana L. Watkins, James A. Blumenthal, Jonathan R. T. Davidson, Michael A.
Babyak, Charles B. McCants,
Jr, Michael H. Sketch, Jr
Psychosomatic Medicine
68:651-656 (2006)
Clinical predictors of early fluoxetine
treatment response in obsessive-compulsive disorder
Eric A. Storch,
Michael J. Larson, Nathan A. Shapira, Herbert E.
Ward, Tanya K. Murphy, Gary R. Geffken, Holly Valerio, Wayne K. Goodman
Depression and Anxiety. Volume 23, Issue 7, Pages 429 - 433
Axis I and II comorbidities
in subjects with and without nocturnal panic
Umberto Albert,
Giuseppe Maina, Chiara Bergesio, Filippo Bogetto
Depression and Anxiety. Volume 23, Issue 7, Pages 422 - 428
Retrospective analysis of psychomotor
agitation, hypomanic symptoms, and suicidal ideation
in unipolar depression
Paolo Olgiati,
Alessandro Serretti, Cristina Colombo
Depression and Anxiety. Volume 23, Issue 7 , Pages 389 - 397
Dose
escalation for insufficient response to standard-dose selective serotonin
reuptake inhibitors in major depressive disorder.
Systematic review
HENRICUS G. RUHÉ, JOCHANAN HUYSER, JAN A.
SWINKELS, and AART H. SCHENE
The British Journal of Psychiatry (2006) 189:
309-316
Personality and Major Depression. A Swedish Longitudinal, Population-Based Twin Study
Kenneth S. Kendler, Margaret
Gatz, Charles O. Gardner, Nancy L. Pedersen
Arch Gen Psychiatry. 2006;63:1113-1120
Antidepressant Efficacy of the Antimuscarinic
Drug Scopolamine. A Randomized,
Placebo-Controlled Clinical Trial
Maura L. Furey, Wayne C.
Drevets
Arch
Gen Psychiatry. 2006;63:1121-1129
Treatment of Posttraumatic Stress Disorder With Venlafaxine Extended Release.
A 6-Month Randomized Controlled Trial
Jonathan Davidson, David Baldwin, Dan J. Stein,
Enrique Kuper, Isma Benattia, Saeed Ahmed, Ron
Pedersen, Jeff Musgnung
Arch
Gen Psychiatry. 2006;63:1158-1165
Treatment-resistant
depression. Are
atypical antipsychotics effective
and safe enough?
Shelton RC
Curr Psychiatry. VOL. 5, NO. 10 / OCTOBER 2006
Lithium augmentation of topiramate
for bipolar disorder with comorbid binge eating
disorder and obesity
Renu Kotwal,
Anna Guerdjikova, Susan L. McElroy, Paul E. Keck Jr
Human
Psychopharmacology: Clinical and Experimental. Volume 21, Issue 7, Pages 425 - 431
Effect of risperidone
on plasma catecholamine metabolites and brain-derived neurotrophic
factor in patients with bipolar disorders
Reiji Yoshimura, Yuichiro
Nakano, Hikaru Hori, Atsuko Ikenouchi,
Nobuhisa Ueda, Jun Nakamura
Human
Psychopharmacology: Clinical and Experimental. Volume 21, Issue 7, Pages 433 - 438
Verbal memory performance during subchronic challenge with a selective serotonergic
and a mixed action antidepressant
M. Wingen, S.
Langer, J. G. Ramaekers
Human
Psychopharmacology: Clinical and Experimental. Volume 21, Issue 7, Pages 473 - 479
The Hypothalamic-Pituitary-Adrenal Axis: What can it Tell
us About Stressors?
Armario, Antonio
CNS
& Neurological Disorders – Drug Targets. Volume 5, Number 5, October 2006, pp. 485-501(17)
Stress and Brain Atrophy
Douglas Bremner, J
CNS & Neurological Disorders -
Drug Targets. Volume
5, Number 5, October 2006, pp. 503-512(10)
Pharmacological
profile of antidepressants: a likely basis for their efficacy and side effects?
European Neuropsychopharmacology. Volume 16, Supplement 5, September 2006, Pages
S625-S632
Major depressive
disorders: clinical efficacy and tolerability of agomelatine,
a new melatonergic agonist
Stuart A.
Montgomery
European Neuropsychopharmacology. Volume 16, Supplement 5, September 2006, Pages
S633-S638
Acute Depressed Mood as a Trigger of Acute
Coronary Syndromes
Andrew Steptoe,
Philip C. Strike, Linda Perkins-Porras, Jean R. McEwan and Daisy L. Whitehead
Biological Psychiatry. Volume 60, Issue 8, 15 October 2006, Pages 837-842
Impairment of Endothelial Function in Unipolar and Bipolar Depression
Janusz K. Rybakowski, Andrzej Wykretowicz, Agnieszka Heymann-Szlachcinska and Henryk Wysocki
Biological Psychiatry. Volume 60, Issue 8, 15 October 2006, Pages 889-891
Citalopram and suicidality in adult major depression and anxiety disorders
Anders G. Pedersen
Nordic
Journal of Psychiatry . Volume 60, Number 5 / October 2006: 392 - 399
Which factors are
important predictors of non-recovery from major depression? A 2-year
prospective observational study
Heimo Viinamäki, Kaisa
Haatainen, Kirsi Honkalampi, Antti Tanskanen, Heli Koivumaa-Honkanen, Risto
Antikainen, Minna Valkonen-Korhonen, Jukka Hintikka
Nordic Journal of Psychiatry. Volume 60, Number 5 / October 2006: 410 - 416
Diagnosing Major Depressive
Disorder VIII: Are Some Symptoms Better Than Others?
McGlinchey,
Joseph B; Zimmerman, Mark; Young, Diane; Chelminski, Iwona
Journal of Nervous & Mental
Disease. 194(10):785-790, October
2006
Lower urinary tract symptoms and depressive
symptoms in elderly men
Samuel Y.S. Wong,
Athena Hong, Jason Leung, Timothy Kwok, Ping C. Leung and Jean Woo
Journal of Affective Disorders. Volume 96, Issues 1-2, November 2006, Pages 83-88
Randomized, double-blind pilot trial
comparing lamotrigine versus citalopram for the
treatment of bipolar depression
Ayal
Schaffer, Pamela Zuker and Anthony Levitt
Journal of Affective Disorders. Volume 96, Issues 1-2, November 2006, Pages 95-99
Phenytoin as an augmentation for SSRI
failures: A small controlled study
B. Shapira, B. Nemets, A.
Trachtenberg and R.H. Belmaker
Journal of Affective Disorders. Volume 96, Issues 1-2, November 2006, Pages 123-126
Approximate
entropy of self-reported mood prior to episodes in bipolar disorder
Tasha Glenn, Peter C Whybrow, Natalie Rasgon, Paul Grof,
Martin Alda, Christopher Baethge
and Michael Bauer
Bipolar Disorders.
Volume 8 Page 424 - October 2006
Placebo-level
incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar
mania
Henry A Nasrallah, Martin Brecher
and Björn Paulsson
Bipolar Disorders.
Volume 8 Page 467 - October 2006
Allopurinol as an adjunct to lithium
and haloperidol for treatment of patients with acute mania: a double-blind,
randomized, placebo-controlled trial
Shahin
Akhondzadeh, Mehdi Rafiee Milajerdi, Homayoun Amini and Mehdi Tehrani-Doost
Bipolar Disorders. Volume 8 Page 485 - October 2006
Aggression and substance
abuse in bipolar disorder
Michael
F Grunebaum, Hanga C Galfalvy, C Matthew Nichols, Nathilee
A Caldeira, Leo Sher, Kanita Dervic, Ainsley K Burke, J John Mann and Maria A Oquendo
Bipolar Disorders. Volume 8 Page 496 - October 2006
Carnitine does
not improve weight loss outcomes in valproate-treated
bipolar patients consuming an energy-restricted, low-fat diet
Jane L Elmslie, Richard J Porter, Peter R Joyce,
Penelope J Hunt and Jim I Mann
Bipolar Disorders. Volume 8 Page 503 - October 2006
How have the selective
serotonin reuptake inhibitor antidepressants affected suicide mortality?
Wayne
D. Hall , Jayne Lucke
Australian and New Zealand Journal of Psychiatry. Volume 40 Page 941 -
November/December 2006
Predictors of depression
12 months after cardiac hospitalization: the Identifying Depression as a Comorbid Condition study
Geoff
Schrader , Frida Cheok , Ann-Louise Hordacre ,
Julie Marker
Australian and New Zealand Journal of Psychiatry. Volume 40 Page 1025 -
November/December 2006
A prospective study of the
association of cerebrospinal fluid monoamine metabolite levels with lethality
of suicide attempts in patients with bipolar disorder
Leo
Sher, Juan J Carballo,
Michael F Grunebaum, Ainsley
K Burke, Gil Zalsman, Yung-yu
Huang, J John Mann and Maria A Oquendo
Bipolar Disorders. Volume 8 Page 543 - October 2006
Correlates of suicide
attempt history in bipolar disorder: a stress-diathesis perspective
Michael
F Grunebaum, Sarah R Ramsay, Hanga
C Galfalvy, Steven P Ellis, Ainsley
K Burke, Leo Sher, David J Printz,
David A Kahn, J John Mann and Maria A Oquendo
Bipolar Disorders. Volume 8 Page 551 - October 2006
A comparison of
the medical lethality of suicide attempts in bipolar and major depressive
disorders
Gil Zalsman, Melanie Braun, Mikkel Arendt, Michael F Grunebaum,
Leo Sher, Ainsley K Burke,
David A Brent, Sadia R Chaudhury,
J John Mann and Maria A Oquendo
Bipolar Disorders.
Volume 8 Page 558 - October 2006
Prospective
predictors of suicide and suicide attempts in 1,556 patients with bipolar disorders
followed for up to 2 years
Lauren B Marangell, Mark S Bauer, Ellen B Dennehy, Stephen R Wisniewski, Michael H Allen, David J Miklowitz, Maria A Oquendo, Ellen
Frank, Roy H Perlis, James M Martinez, Andrea Fagiolini,
Michael W Otto, Cheryl A Chessick, Holly A Zboyan, Sachiko Miyahara, Gary Sachs and Michael E Thase
Bipolar Disorders.
Volume 8 Page 566 - October 2006
Prospective study
of risk factors for attempted suicide among patients with bipolar disorder
Hanna M Valtonen, Kirsi Suominen, Outi Mantere,
Sami Leppämäki, Petri Arvilommi and Erkki T Isometsä
Bipolar Disorders.
Volume 8 Page 576 - October 2006
Clinical predictors of
suicidal acts after major depression in bipolar disorder: a prospective study
Hanga
Galfalvy, Maria A Oquendo,
Juan J Carballo, Leo Sher,
Michael F Grunebaum, Ainsley
Burke and J John Mann
Bipolar Disorders. Volume 8 Page 586 - October 2006
Antidepressants
and suicidal behavior in bipolar disorder
Susan L McElroy, Renu Kotwal, Rakesh Kaneria and
Paul E Keck Jr
Bipolar Disorders.
Volume 8 Page 596 - October 2006
Suicidal risk in
bipolar I disorder patients and adherence to long-term lithium treatment
Ana Gonzalez-Pinto, Fernando Mosquera, Marta
Alonso, Purificación López,
Fernando Ramírez, Eduard Vieta
and Ross J Baldessarini
Bipolar Disorders.
Volume 8 Page 618 - October 2006
Decreased risk of
suicides and attempts during long-term lithium treatment: a meta-analytic
review
Ross J Baldessarini, Leonardo Tondo, Paula Davis, Maurizio Pompili,
Frederick K Goodwin and John Hennen
Bipolar Disorders. Volume 8 Page 625 - October 2006
Lifetime rhythmicity and
mania as correlates of suicidal ideation and attempts in mood disorders.
M. Balestrieri, P. Rucci, A. Sbrana, L. Ravani, A. Benvenuti, C.
Gonnelli, L. Dell'Osso, G. Cassano
Comprehensive
Psychiatry, Volume 47, Issue 5, Pages 334-341
Effect of depression on
all-cause mortality in adults with cancer and differential effects by cancer
site
Adedayo A. Onitilo, Paul J. Nietert, Leonard E. Egede
Gen Hosp Psychiatry. Volume 28, Issue 5, Pages
396-402 (September 2006)
Recognizing Increased
Risk of Depressive
Comorbidity after Myocardial Infarction: Looking for 4 Symptoms
of Anxiety-Depression
Johan Denollet, Jacqueline J. Strik, Richel Lousberg,
Adriaan Honig
Psychotherapy
and Psychosomatics 2006;75:346-352
Panic disorder during pregnancy
and postpartum period
Borwin Bandelow, Felicita Sojka, Andreas Broocks, Göran Hajak, Stefan Bleich and Eckart Rüther
European Psychiatry. Volume 21, Issue 7, October 2006, Pages 495-500
Interferon-induced
depressive illness in hep C patients responds to SSRI
antidepressant treatments
, | , |
Neuropsychiatric Disease and Treatment. Volume: 2 | Issue: 3: 355-358
A Randomized,
Placebo-Controlled, Multicenter Study of Divalproex
Sodium Extended Release in the Treatment of Acute Mania
Charles L. Bowden, Alan C. Swann, Joseph R.
Calabrese, Leon M. Rubenfaer, Patricia J. Wozniak,
Michelle A. Collins, Walid Abi-Saab,
and Mario Saltarelli, for the Depakote
ER Mania Study Group
J Clin Psychiatry 2006;67:1501-1510
Open-Label Trial of
Escitalopram in the Treatment of Posttraumatic Stress
Disorder
Sophie Robert, Mark B. Hamner,
Helen G. Ulmer, Jeffrey P. Lorberbaum, and Valerie L.
Durkalski
J Clin Psychiatry 2006;67:1522-1526
Subsyndromal
Depressive Symptoms Are Associated With Functional Impairment in Patients With Bipolar Disorder: Results of a Large, Multisite Study
Lori L. Altshuler,
Robert M. Post, David O. Black, Paul E. Keck, Jr., Willem A. Nolen, Mark A.
Frye, Trisha Suppes, Heinz Grunze,
Ralph W. Kupka, Gabriele S. Leverich,
Susan L. McElroy, Joerg Walden, and Jim Mintz
J Clin Psychiatry 2006;67:1551-1560
Safety and Efficacy
of Levetiracetam for Patients With
Panic Disorder: Results of an Open-Label, Fixed-Flexible Dose Study
Laszlo A. Papp
J Clin Psychiatry 2006;67:1573-1576
Sex Differences in
Depressive Response During Monoamine Depletions in
Remitted Depressive Subjects
Francisco A. Moreno, Cynthia A. McGahuey, Marlene P. Freeman, and Pedro L. Delgado
J Clin Psychiatry 2006;67:1618-1623
Three-Year
Outcomes in Deep Brain Stimulation for Highly Resistant Obsessive–Compulsive
Disorder
Benjamin
D Greenberg, Donald A Malone, Gerhard M Friehs,
Ali R Rezai, Cynthia S Kubu,
Paul F Malloy, Stephen P Salloway, Michael
S Okun, Wayne K Goodman and Steven
A Rasmussen
Neuropsychopharmacology (2006) 31, 2384–2393
Effects
of Risperidone Augmentation in Patients with
Treatment-Resistant Depression: Results of Open-Label Treatment Followed by
Double-Blind Continuation
Mark Hyman Rapaport, Georges M Gharabawi,
Carla M Canuso, Ramy
A Mahmoud, Martin B Keller, Cynthia A Bossie, Ibrahim Turkoz, Robert A Lasser, Amy Loescher, Philippe Bouhours,
Fiona Dunbar and Charles B Nemeroff
Neuropsychopharmacology (2006) 31, 2505–2513
Depressive
symptoms and insulin resistance in young adult males: results from the
M Timonen, U Rajala, J Jokelainen, S Keinänen-Kiukaanniemi,
V B Meyer-Rochow and P Räsänen
Molecular Psychiatry (2006) 11,
929–933
Double-Blind, Randomized, Placebo-Controlled
Trials of Ethyl-Eicosapentanoate in the Treatment of
Bipolar Depression and Rapid Cycling Bipolar Disorder
Paul E. Keck, Jr.,
Jim Mintz, Susan L. McElroy, Marlene P. Freeman,
Trisha Suppes, Mark A. Frye, Lori L. Altshuler, Ralph Kupka, Willem A.
Nolen, Gabriele S. Leverich, Kirk D. Denicoff, Heinz Grunze, Naihua Duan and Robert M. Post
Biological Psychiatry. Volume
60, Issue 9, 1 November 2006, Pages 1020-1022
Clinical correlates of first-episode
polarity in bipolar disorder
Claire Daban, Francesc Colom, Jose Sanchez-Moreno, Margarita García-Amador
and Eduard Vieta
Comprehensive Psychiatry. Volume 47, Issue 6, November-December 2006, Pages 433-437
One in 10 elderly
people with minor or subsyndromal depression develops
major depression within a year
Lyness JM, Heo
M, Datto CJ, et al.
Evidence-Based Mental Health 2006;9:94
Review:
psychotherapy plus antidepressant therapy increases response rate in people
with panic disorder more than either treatment alone
Furukawa TA, Watanabe N, Churchill R
Evidence-Based Mental Health 2006;9:98
Major depressive
disorder: similar remission rates with bupropion, sertraline, or venlafaxine
following treatment switch from citalopram
Rush AJ, Trivedi
MH, Wisniewski SR, et al.
Evidence-Based Mental Health 2006;9:100
Continuing paroxetine treatment reduces recurrence of major depression
in the elderly
Reynolds CF, Dew MA, Pollock BG, et al.
Evidence-Based Mental Health 2006;9:101
Entering menopause
increases the risk of first episode depression
Cohen LS, Soares CN,
Vitonis AF, et al.
Evidence-Based Mental Health 2006;9:109
The menopausal
transition increases the risk of depressive symptoms and depression diagnosis
in women without a history of depression
Freeman EW, Sammel
MD, Lin H, et al.
Evidence-Based Mental Health 2006;9:110
Depressive symptoms
in elderly people are associated with an increased risk of developing mild
cognitive impairment independently of vascular disease
Evidence-Based Mental Health 2006;9:111
Lifetime prevalence
of panic disorder is about 5% in the
Grant BF, Hasin DS,
Stinson FS, et al.
Evidence-Based Mental Health 2006;9:114
Review: worldwide
lifetime prevalence of anxiety disorders is 16.6%, with considerable
heterogeneity between studies
Somers JM, Goldner
EM, Waraich P, et
al.
Evidence-Based Mental
Health 2006;9:115
Impact of Prior
Treatment Exposure on Response to Antidepressant Treatment in Late Life
James D. Tew Jr,
Benoit H. Mulsant, Patricia R. Houck, Eric J. Lenze, Ellen M. Whyte, Mark D. Miller,
Jacqueline A. Stack, Salem Bensasi, and Charles F.
Reynolds III
Am J Geriatr Psychiatry
14:957-965, November 2006
The Prognosis of
Major and Minor Depression in Older Medical Inpatients
Martin G. Cole, Jane McCusker, Antonio Ciampi, Sylvia Windholz, Eric
Latimer, and Eric Belzile
Am J Geriatr Psychiatry 14:966-975, November 2006
Double
depression: its morbidity and management in a community setting
Robert D. Goldney, Marcus A. Bain
Acta Neuropsychiatrica. Volume 18 Page 210 -
October 2006
Evidence for respiratory and nonrespiratory subtypes in panic disorder
Kenneth Abrams, Yuri Rassovsky,
Matt G. Kushner